Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Mouse models of type I interferonopathies

Type I Interferons in the Pathogenesis and Treatment of Sjögren’s Syndrome: an Update

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway

Novel interferonopathies associated with mutations in RIG-I like receptors

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion

Type I Interferons Promote Severe Disease in a Mouse Model of Lethal Ehrlichiosis

Human life within a narrow range: The lethal ups and downs of type I interferons

Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy

CNS disease associated with enhanced type I interferon signalling

Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency

Type I Interferons and Il-12: Convergence and Cross Regulation among Mediators of Cellular Immunity.

Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor -Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains

Type I interferons in infectious disease

RIG-I-like receptors and autoimmune diseases

cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing

Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity

Interferon stimulated immune profile changes in a humanized mouse model of HBV infection